Literature DB >> 20142247

Concurrent infection with multiple human papillomavirus types: pooled analysis of the IARC HPV Prevalence Surveys.

Salvatore Vaccarella1, Silvia Franceschi, Peter J F Snijders, Rolando Herrero, Chris J L M Meijer, Martyn Plummer.   

Abstract

To understand viral interactions and the cross-reactivity of natural or vaccine-induced responses, we investigated whether multiple human papillomavirus (HPV) infections, particularly certain combinations of types, have the tendency to cluster together. Cervical cell samples were collected from women in the framework of the IARC HPV Prevalence Surveys. Women with a cytology diagnosis of high-grade squamous intraepithelial lesion or worse were excluded, leaving 13,961 women for this analysis. HPV DNA was assessed using a general GP5+/6+ primer-mediated PCR. HPV genotyping was done using enzyme immunoassay or reverse line blot analysis. Logistic regression with type-specific HPV positivity as an outcome was used, adjusted for age, study area, and lifetime number of sexual partners. Woman-level random effects were added to represent unobservable risk factors common to all HPV types. The observed-to-expected ratio was 1.20 (95% credible interval, 1.14-1.26) for infection with two HPV types and 1.02 (95% credible interval, 0.91-1.12) for three for more types, with the best possible adjustment. Among combinations of specific HPV types, the tendency to cluster increased with the genetic similarity of the L1 region. High observed-to-expected ratios were found for closely homologous types, including HPV33/58, 18/45, 33/35, and 31/35. The excess of multiple infections, however, was clearly evident only when enzyme immunoassay, and not reverse line blot, was used as the genotyping method. The different results by genotyping method suggest that the apparent clustering of HPV infections was an artifact of the measurement process. Further investigation is required to evaluate other widely used HPV detection methods.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20142247     DOI: 10.1158/1055-9965.EPI-09-0983

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  46 in total

1.  Logistic analysis of epidemiologic studies with augmentation sampling involving re-stratification and population expansion.

Authors:  Yan Li; Mahboobeh Safaeian; Hilary A Robbins; Barry I Graubard
Journal:  Biostatistics       Date:  2014-06-06       Impact factor: 5.899

2.  Multiple human papillomavirus infections and type competition in men.

Authors:  Anne F Rositch; Charles Poole; Michael G Hudgens; Kawango Agot; Edith Nyagaya; Stephen Moses; Peter J F Snijders; Chris J L M Meijer; Robert C Bailey; Jennifer S Smith
Journal:  J Infect Dis       Date:  2011-11-04       Impact factor: 5.226

3.  Clustering of multiple human papillomavirus infections in women from a population-based study in Guanacaste, Costa Rica.

Authors:  Salvatore Vaccarella; Silvia Franceschi; Rolando Herrero; Mark Schiffman; Ana Cecilia Rodriguez; Allan Hildesheim; Robert D Burk; Martyn Plummer
Journal:  J Infect Dis       Date:  2011-08-01       Impact factor: 5.226

4.  High Rate of Multiple Concurrent Human Papillomavirus Infections among HIV-Uninfected South African Adolescents.

Authors:  David Adler; Fatima Laher; Melissa Wallace; Katherine Grzesik; Heather Jaspan; Linda-Gail Bekker; Glenda Gray; Ziyaad Valley-Omar; Bruce Allan; Anna-Lise Williamson
Journal:  J Immunol Tech Infect Dis       Date:  2013

5.  Evaluation of human papillomavirus type replacement postvaccination must account for diagnostic artifacts: masking of HPV52 by HPV16 in anogenital specimens.

Authors:  Joseph E Tota; Agnihotram V Ramanakumar; Luisa L Villa; Harriet Richardson; Ann N Burchell; Anita Koushik; Marie-Hélène Mayrand; François Coutlée; Eduardo L Franco
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-10-02       Impact factor: 4.254

6.  Vaccine-relevant human papillomavirus (HPV) infections and future acquisition of high-risk HPV types in men.

Authors:  Anne F Rositch; Michael G Hudgens; Danielle M Backes; Stephen Moses; Kawango Agot; Edith Nyagaya; Peter J F Snijders; Chris J L M Meijer; Robert C Bailey; Jennifer S Smith
Journal:  J Infect Dis       Date:  2012-06-18       Impact factor: 5.226

7.  Clustering of human papillomavirus (HPV) types in the male genital tract: the HPV in men (HIM) study.

Authors:  Salvatore Vaccarella; Martyn Plummer; Silvia Franceschi; Patti Gravitt; Mary Papenfuss; Danelle Smith; Luisa Villa; Eduardo Lazcano Ponce; Anna R Giuliano
Journal:  J Infect Dis       Date:  2011-09-09       Impact factor: 5.226

8.  The epidemiology of oral HPV infection among a multinational sample of healthy men.

Authors:  Aimee R Kreimer; Alessandro Villa; Alan G Nyitray; Martha Abrahamsen; Mary Papenfuss; Danelle Smith; Allan Hildesheim; Luisa L Villa; Eduardo Lazcano-Ponce; Anna R Giuliano
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-12-10       Impact factor: 4.254

9.  Invited commentary: multiple human papillomavirus infections and type replacement-anticipating the future after human papillomavirus vaccination.

Authors:  Mahboobeh Safaeian; Ana Cecilia Rodriguez
Journal:  Am J Epidemiol       Date:  2014-10-29       Impact factor: 4.897

10.  Lineages of oncogenic human papillomavirus types other than type 16 and 18 and risk for cervical intraepithelial neoplasia.

Authors:  Long Fu Xi; Mark Schiffman; Laura A Koutsky; James P Hughes; Rachel L Winer; Constance Mao; Ayaka Hulbert; Shu-Kuang Lee; Zhenping Shen; Nancy B Kiviat
Journal:  J Natl Cancer Inst       Date:  2014-09-13       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.